Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EPM2A in-frame deletion slows neurological decline in Lafora Disease.

Seizure - 1 Oct 2021

Lomax Lysa Boissé, Verhalen Brandy, Minassian Berge A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Glycogen Storage Diseases and Myoclonus
Share to Lafora Disease
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neurological disorders and treatments

Share to Protein Tyrosine Phosphatases, Non-Receptor

Share to Sequence Deletion

Source

Open in PubMed Open full text

Identifiers

PMID: 34147889
DOI: 10.1016/j.seizure.2021.06.002
PMCID: PMC8434975

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EPM2A in-frame deletion slows neurological decline in Lafora Disease.PMID 34147889Read ↗

A novel EPM2A mutation in a patient with Lafora disease presenting with early parkinsonism symptoms in childhood.Semantic proximity Read ↗

Novel human pathological mutations. Gene symbol: EPM2A. Disease: Lafora progressive myoclonus epilepsy.Semantic proximity Read ↗

Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletionsSemantic proximity Read ↗

Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.Semantic proximity Read ↗

Novel mutation of EPM2A causes progressive myoclonic epilepsy: a case report.Semantic proximity Read ↗

Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.Semantic proximity Read ↗

Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.Semantic proximity Read ↗

Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (<i>EPM2B</i>) on 6p22Semantic proximity Read ↗

Expanding the Phenotypic Variability of PMPCA-Related Ataxia.Semantic proximity Read ↗

Novel EXOSC3 pathogenic variant results in a mild course of neurologic disease with cerebellum involvementSemantic proximity Read ↗

Current Advances and Challenges in Gene Therapies for Neurologic DisordersSemantic proximity Read ↗

Exome‐Wide Analyses in Paroxysmal Kinesigenic Dyskinesia Confirm <scp> <i>TMEM151A</i> </scp> as a Novel Causative GeneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.